| Date | Form | Description | Docs | XBRL | Pages |
| 09/10/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/10/12 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
28 | |
| 09/10/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/05/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/05/12 | 8-K | Current report filing |
|
8 | |
| 08/30/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/27/12 | 8-K | Current report filing |
|
24 | |
| 06/14/12 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
46 |
| 03/16/12 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
44 |
| 01/30/12 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
|
94 |
Latest News & Events
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
Read More...Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
Read More...Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Read More...